All Pathways
Orthopedic SurgeryManagement

Hip Fracture Management in Older Adults (AAOS 2021/NICE)

Hip Fracture Management in Older Adults (AAOS 2021/NICE): Suspected Hip Fracture in Older Adult → Initial Assessment → Fracture visible on X-ray? → MRI ...

Pathway Overview

19 steps

Algorithm Steps

19 total

  1. 01Start

    Suspected Hip Fracture in Older Adult

    Age ≥55 with hip pain after fall or trauma

  2. 02Action

    Initial Assessment

    History, exam, and imaging

    • Pain in groin, lateral hip, or referred to knee
    • Inability to weight bear
    • Shortened, externally rotated leg
    • AP and lateral hip X-rays
    • Check for other injuries (wrist, spine)
  3. 03Decision

    Fracture visible on X-ray?

    Initial radiograph interpretation

  4. 04Action

    MRI for Occult Fracture

    AAOS: Moderate evidence supports MRI

    • MRI is imaging of choice if X-ray negative
    • Obtain within 24 hours
    • CT if MRI unavailable or contraindicated
    • Do not delay if high clinical suspicion
  5. 05Decision

    Classify Hip Fracture Type

    Intracapsular vs Extracapsular

    • Intracapsular: Femoral neck fractures
    • Extracapsular: Intertrochanteric, Subtrochanteric
    • Assess displacement and stability
  6. 06Action

    Preoperative Optimization

    Prepare for surgery within 24-48h

    • AAOS: Surgery within 24-48h improves outcomes
    • Assess cardiac, pulmonary status
    • Manage anticoagulation (bridging if needed)
    • Correct electrolytes, anemia (transfuse if Hgb <8)
    • NPO status, IV fluids
    • Pain control (femoral nerve block if available)
    • VTE prophylaxis
  7. 07Warning

    ⚠️ High Mortality Risk

    Hip fracture carries significant mortality

    • 30-day mortality ~10%
    • 1-year mortality ~30%
    • Delay >48h associated with worse outcomes
    • Optimize medically but do not delay unnecessarily
  8. 08Decision

    Femoral Neck Fracture: Displaced?

    Garden III/IV vs Garden I/II

  9. 09Action

    Non-displaced Femoral Neck (Garden I/II)

    Internal fixation preferred

    • Cannulated screws (typically 3)
    • Sliding hip screw (SHS) acceptable
    • Lower risk of AVN than displaced
    • Close follow-up for displacement
  10. 10Action

    Postoperative Care

    Multidisciplinary hip fracture program

    • Mobilize day 1 post-op (NICE)
    • Weight bearing as tolerated (most cases)
    • DVT prophylaxis 28-35 days
    • Delirium prevention
    • Nutritional support
    • Osteoporosis assessment and treatment
    • Falls prevention program
  11. 11Outcome

    Recovery & Rehabilitation

    Return to baseline function is goal

  12. 12Decision

    Displaced Femoral Neck: Patient Factors

    Age, activity, cognition, life expectancy

  13. 13Action

    Total Hip Replacement (THR)

    NICE: Offer THR for displaced FNF if appropriate

    • Independently mobile pre-fracture
    • Cognitively intact
    • Medically fit for larger procedure
    • Better functional outcomes than HA
    • Use cemented femoral stem (AAOS moderate evidence)
  14. 14Action

    Tranexamic Acid (TXA)

    AAOS: Moderate evidence to reduce blood loss

    • 1-2g IV before incision
    • Reduces transfusion requirements
    • Low VTE risk in appropriate patients
    • Consider topical in wound
  15. Path rejoins step 10Shared downstream outcome
  16. 15Action

    Hemiarthroplasty (HA)

    For displaced FNF when THR not suitable

    • Cognitive impairment
    • Limited mobility pre-fracture
    • Shorter life expectancy
    • Use cemented stem (AAOS moderate evidence)
    • Unipolar or bipolar head
  17. Path rejoins step 14Shared downstream outcome
  18. 16Decision

    Intertrochanteric Fracture: Stable?

    AO/OTA classification, lateral wall integrity

  19. 17Action

    Stable Intertrochanteric (A1)

    NICE: Extramedullary implant preferred

    • Sliding Hip Screw (SHS/DHS)
    • Simple 2-part fracture pattern
    • Intact lateral wall
    • Lower implant cost, similar outcomes
  20. Path rejoins step 14Shared downstream outcome
  21. 18Action

    Unstable Intertrochanteric (A2/A3)

    AAOS: Cephalomedullary device recommended

    • Intramedullary nail (IMN) preferred
    • Reverse oblique, subtrochanteric extension
    • Lateral wall incompetence
    • Short vs long nail based on pattern
  22. Path rejoins step 14Shared downstream outcome
  23. 19Action

    Subtrochanteric Fracture

    Below lesser trochanter

    • Cephalomedullary nail (long)
    • Consider ORIF with fixed-angle device
    • High stress region - malunion/nonunion risk
    • Often associated with bisphosphonate use
  24. Path rejoins step 14Shared downstream outcome
  25. Path rejoins step 05Shared downstream outcome

Guideline Source

AAOS CPG: Management of Hip Fractures in Older Adults + NICE CG124

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Applies to adults ≥55 years (AAOS), ≥65 for some NICE recommendations
  • Does not cover pathologic fractures from malignancy
  • Implant selection may vary by surgeon preference and availability
  • Anticoagulation management complex - individualized approach needed

Applicable Regions

USEU

UK: NICE CG124 guides practice - Best Practice Tariff applies

US: AAOS 2021 primary reference

Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Hip Fracture Management in Older Adults (AAOS 2021/NICE)?

The Hip Fracture Management in Older Adults (AAOS 2021/NICE) is a management clinical algorithm for Orthopedic Surgery. It provides a structured decision tree to guide clinical decision-making, based on AAOS CPG: Management of Hip Fractures in Older Adults + NICE CG124.

What guideline is the Hip Fracture Management in Older Adults (AAOS 2021/NICE) based on?

This algorithm is based on AAOS CPG: Management of Hip Fractures in Older Adults + NICE CG124 (DOI: 10.5435/JAAOS-D-21-00302).

What are the limitations of the Hip Fracture Management in Older Adults (AAOS 2021/NICE)?

Known limitations include: Applies to adults ≥55 years (AAOS), ≥65 for some NICE recommendations; Does not cover pathologic fractures from malignancy; Implant selection may vary by surgeon preference and availability; Anticoagulation management complex - individualized approach needed. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Hip Fracture Management in Older Adults (AAOS 2021/NICE) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free